SUN Pharma East Africa Limited Pharmaceutical Import Profile — Kenya (DGFT 2022–2026)

Name: SUN Pharma East Africa Limited Pharmaceutical Import Records from India — 4 Products, $742.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

SUN Pharma East Africa Limited — Pharmaceutical Importer Profile (2026) | 4 Products, $742.5K Trade | TransData Nexus

SUN Pharma East Africa Limited

Pharmaceutical Importer · Kenya · Respiratory & OTC Focus · $742.5K Total Trade · DGFT Verified

SUN Pharma East Africa Limited is a pharmaceutical importer based in Kenya with a total trade value of $742.5K across 4 products in 3 therapeutic categories. Based on 27 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. SUN Pharma East Africa Limited sources from 1 verified Indian supplier, with Sun Pharmaceutical Industries Limited accounting for 100.0% of imports.

SUN Pharma East Africa Limited — Import Portfolio & Supplier Network

SUN Pharma East Africa Limited import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to SUN Pharma East Africa Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$7.3M	353	100.0%

SUN Pharma East Africa Limited sources from 1 verified Indian supplier across 296 distinct formulations. The sourcing is highly concentrated — Sun Pharmaceutical Industries Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Cetrizet d tablets (containing	$100.0K	2
Qutipin 200 MG tablets (quetiapine	$98.3K	2
Pantocid 40 tabs pantoprazole sodium	$94.5K	2
Duzela 30 MG CAPS (duloxetine	$94.0K	4
Volini gel 30GM fwa roa (Pack:1 tube)	$87.6K	3
Ranferon -12 capsules Each capsule	$80.0K	4
Susten 400 MG capsules progesterone soft gelatin capsules 400MG Pack : box3x10s sap code	$79.2K	5
Etoday TAB 90MG contains etoricoxib	$74.4K	3
Brustan tablets Each tablet contains	$71.1K	2
Cetrizet d tablets contains(containing	$67.7K	2
Contiflo od cap 0.4 MG 10's roa	$64.6K	2
Irovel 300 MG tablets irbesartan	$64.1K	3
Cetrizet-d tablets contains (cetirizinehcl 5MG and pseudoephedrine hcl 120 MG/TAB )bno: jmg0054a mfd. 03/25	$58.2K	2
Zosert TAB 50MG Pack : box3x10s batch :dff0970b Each TAB conts sertraline hcl TAB BP 50MG	$55.0K	3
Rozavel TAB 10MG Each tablets contains	$50.0K	1

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Alprazolam	CNS & Psychiatric	$295.4K	16	1.8%	11
2	Ephedrine	Respiratory & OTC	$172.9K	4	0.8%	16
3	Pseudoephedrine	Respiratory & OTC	$172.9K	4	1.4%	9
4	Volini	Brand Names & OTC Products	$101.4K	3	3.4%	9

SUN Pharma East Africa Limited imports 4 pharmaceutical products across 3 categories into Kenya totaling $742.5K.

SUN Pharma East Africa Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

SUN Pharma East Africa Limited is a pharmaceutical importer and distributor based in Nairobi, Kenya. As a subsidiary of Sun Pharmaceutical Industries Limited, an Indian multinational pharmaceutical company headquartered in Mumbai, India, SUN Pharma East Africa Limited plays a pivotal role in the distribution of pharmaceutical products within the East African region. The parent company, Sun Pharmaceutical Industries Limited, is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company globally, with a presence in over 100 countries.

In Kenya, SUN Pharma East Africa Limited serves as a key player in the pharmaceutical supply chain, importing and distributing a diverse range of finished pharmaceutical formulations. The company's operations are integral to ensuring the availability of essential medications across the country, thereby contributing significantly to the healthcare sector.

2Distribution Network

SUN Pharma East Africa Limited operates a centralized distribution model from its headquarters in Nairobi, Kenya. While specific details regarding warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in Nairobi enables efficient distribution throughout Kenya and potentially to neighboring East African countries. This centralization facilitates streamlined operations and effective management of the supply chain, ensuring timely delivery of pharmaceutical products to various healthcare providers and retailers.

3Industry Role

In Kenya's pharmaceutical supply chain, SUN Pharma East Africa Limited functions primarily as a pharmaceutical importer and distributor. The company imports finished pharmaceutical formulations from its parent company, Sun Pharmaceutical Industries Limited, and other suppliers, and subsequently distributes these products to local wholesalers, pharmacies, hospitals, and clinics. This role is crucial in bridging the gap between international pharmaceutical manufacturers and the Kenyan market, ensuring the availability of a wide range of medications to meet the country's healthcare needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — SUN Pharma East Africa Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

SUN Pharma East Africa Limited's sourcing strategy exhibits a high degree of concentration, with a significant majority of its pharmaceutical imports originating from Sun Pharmaceutical Industries Limited. This single-source dependency may present risks, such as supply chain disruptions due to geopolitical issues, production delays, or regulatory changes affecting the parent company. However, the consistent shipment data over the years indicates a stable and reliable relationship between SUN Pharma East Africa Limited and its parent company, which may mitigate some of these risks. The company's focus on a single supplier suggests a strategic choice aimed at ensuring product consistency and quality, leveraging the established reputation and manufacturing capabilities of Sun Pharmaceutical Industries Limited.

2Supply Chain Resilience

The resilience of SUN Pharma East Africa Limited's supply chain is closely tied to the stability and reliability of its parent company, Sun Pharmaceutical Industries Limited. Given the parent company's extensive global presence and diversified manufacturing facilities, the supply chain is likely robust. However, the lack of publicly available information regarding backup suppliers and the diversity of formulations imported indicates a potential vulnerability due to the high concentration of sourcing. Additionally, the company's reliance on a single supplier may expose it to risks associated with shipping route disruptions and regulatory compliance issues affecting the parent company.

Importing Pharmaceuticals into Kenya — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Kenya

1Regulatory Authority & Framework

In Kenya, the regulation of pharmaceutical products is overseen by the Pharmacy and Poisons Board (PPB), which operates under the Ministry of Health. The PPB is responsible for ensuring that all pharmaceutical products imported, manufactured, and sold in Kenya meet the required standards of safety, efficacy, and quality. Key legislation governing pharmaceutical imports includes the Pharmacy and Poisons Act (Cap. 244) and the Pharmacy and Poisons (Registration of Health Products and Technologies) Rules. These regulations stipulate that no person shall import, manufacture for sale, or sell any drug in Kenya unless that drug has been registered and listed in accordance with the provisions of these rules.

2Import Licensing & GMP

Importers of pharmaceutical products into Kenya are required to obtain an import permit from the Pharmacy and Poisons Board (PPB) for each consignment. This process involves submitting an application that includes detailed information about the product, its manufacturer, and its intended use. Additionally, importers must ensure that the pharmaceutical products comply with Good Manufacturing Practice (GMP) standards. The PPB recognizes GMP certificates from competent regulatory authorities, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must provide evidence of GMP compliance to facilitate the registration and importation process.

SUN Pharma East Africa Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

SUN Pharma East Africa Limited's product strategy focuses on importing and distributing pharmaceutical formulations across three therapeutic categories: Respiratory & OTC, CNS & Psychiatric, and Brand Names & OTC Products. The company's top five imported products—Alprazolam, Ephedrine, Pseudoephedrine, and Volini—align with these categories, indicating a strategic emphasis on addressing prevalent health concerns in the Kenyan market. The significant import value of these products suggests a strong market demand and the company's commitment to providing essential medications to meet the healthcare needs of the population.

2Sourcing Profile

SUN Pharma East Africa Limited's sourcing strategy is predominantly focused on generic drug formulations, with a particular emphasis on products manufactured by its parent company, Sun Pharmaceutical Industries Limited. This approach leverages the established reputation and manufacturing capabilities of the parent company, ensuring access to a wide range of high-quality pharmaceutical products. The company's preference for finished pharmaceutical formulations over raw active pharmaceutical ingredients (APIs) indicates a strategic choice to streamline operations and maintain control over product quality and consistency.

3Market Positioning

Seller's Guide — How to Become a Supplier to SUN Pharma East Africa Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Kenyan market and collaborate with SUN Pharma East Africa Limited. The company's concentrated sourcing pattern suggests potential gaps in its current supply chain that could be addressed by alternative suppliers. By offering high-quality pharmaceutical products that meet Kenyan regulatory standards, new suppliers can position themselves as viable partners, contributing to the diversification and resilience of SUN Pharma East Africa Limited's sourcing strategy.

2Requirements & Qualifications

Indian exporters seeking to supply SUN Pharma East Africa Limited and the Kenyan market must ensure that their pharmaceutical products are registered with the Pharmacy and Poisons Board (PPB) of Kenya. This involves obtaining an import permit for each consignment and providing evidence of compliance with Good Manufacturing Practice (GMP) standards recognized by competent regulatory authorities, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, products must meet labeling requirements, including information in English and Kiswahili, and comply with any serialization mandates to facilitate traceability and prevent counterfeit products.

Frequently Asked Questions — SUN Pharma East Africa Limited

What products does SUN Pharma East Africa Limited import from India?

SUN Pharma East Africa Limited imports 4 pharmaceutical products across 3 categories. Top imports: Alprazolam ($295.4K), Ephedrine ($172.9K), Pseudoephedrine ($172.9K), Volini ($101.4K).

Who supplies pharmaceuticals to SUN Pharma East Africa Limited from India?

SUN Pharma East Africa Limited sources from 1 verified Indian suppliers. The primary supplier is Sun Pharmaceutical Industries Limited (100.0% of imports, $7.3M).

What is SUN Pharma East Africa Limited's total pharmaceutical import value?

SUN Pharma East Africa Limited's total pharmaceutical import value from India is $742.5K, based on 27 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does SUN Pharma East Africa Limited focus on?

SUN Pharma East Africa Limited imports across 3 categories. The largest: Respiratory & OTC (46.6%), CNS & Psychiatric (39.8%), Brand Names & OTC Products (13.7%).

Get Full SUN Pharma East Africa Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

SUN Pharma East Africa Limited

SUN Pharma East Africa Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to SUN Pharma East Africa Limited?

What Formulations Does SUN Pharma East Africa Limited Import?

What Products Does SUN Pharma East Africa Limited Import?

Top Products by Import Value

SUN Pharma East Africa Limited Therapeutic Categories — 3 Specializations